Abbott's programme comes amid calls for continuous ketone monitoring from a number of diabetes specialists, including clinicians on a panel organised by the Diabetes Technology Society ...

Novo Nordisk and devices firm Abbott have announced a partnership that aims to make diabetes management easier by linking technologies such as continuous glucose monitoring with connected insulin ...

Unlike previous, similar devices, the new ones don’t require prescriptions and aren’t just for diabetics. Abbott’s new device, called Lingo, is geared toward people who don’t have diabetes ...